Nasdaq, Inc. (NDAQ - Free Report) reported second-quarter 2019 adjusted earnings per share of $1.22, beating the Zacks Consensus Estimate of $1.19 by 2.5%. The bottom line increased 3.4% year over year.
The company witnessed growth in non-trading revenues and decline in expenses. Strategic acquisitions contributed to revenues in the quarter.
Performance in Detail
Nasdaq’s revenues of $623 million increased 1.3% year over year. The upside was primarily attributable to inclusion of revenues from Cinnober and Quandl acquisitions, partially offset by negative impact of divestitures and unfavorable forex. Organic revenues grew 4%. The top line however missed the Zacks Consensus Estimate of $632 million.
Adjusted operating expenses were $322 million in the reported quarter, down 1% from the year-ago period owing to net impact of acquisitions and divestitures and favorable impact of changes in forex rates, partially offset by organic expense increase.
Operating margin of 48% expanded 100 basis points year over year.
In the U.S. market, Nasdaq welcomed 81 new listings, including 60 IPOs. Nasdaq's Nordic, and Baltic exchanges and Nasdaq First North added 19 new listings, including 14 IPOs.
Nasdaq, Inc. Price, Consensus and EPS Surprise
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Nasdaq, Inc. (NDAQ - Free Report) reported second-quarter 2019 adjusted earnings per share of $1.22, beating the Zacks Consensus Estimate of $1.19 by 2.5%. The bottom line increased 3.4% year over year.
The company witnessed growth in non-trading revenues and decline in expenses. Strategic acquisitions contributed to revenues in the quarter.
Performance in Detail
Nasdaq’s revenues of $623 million increased 1.3% year over year. The upside was primarily attributable to inclusion of revenues from Cinnober and Quandl acquisitions, partially offset by negative impact of divestitures and unfavorable forex. Organic revenues grew 4%. The top line however missed the Zacks Consensus Estimate of $632 million.
Adjusted operating expenses were $322 million in the reported quarter, down 1% from the year-ago period owing to net impact of acquisitions and divestitures and favorable impact of changes in forex rates, partially offset by organic expense increase.
Operating margin of 48% expanded 100 basis points year over year.
In the U.S. market, Nasdaq welcomed 81 new listings, including 60 IPOs. Nasdaq's Nordic, and Baltic exchanges and Nasdaq First North added 19 new listings, including 14 IPOs.
Nasdaq, Inc. Price, Consensus and EPS Surprise
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on NDAQ - FREE
Get the latest research report on DFS - FREE
Get the latest research report on AXP - FREE
Get the latest research report on PGR - FREE